相似文献
1
Cancer: A Multifaceted Enemy and the Precision Oncology Response.
Int J Mol Sci. 2024 May 21;25(11):5577. doi: 10.3390/ijms25115577.
2
Precision oncology: East meets West.
Int J Cancer. 2018 May 1;142(9):1734-1737. doi: 10.1002/ijc.31218. Epub 2018 Jan 4.
3
Perspective on Precision Medicine in Oncology.
Pharmacotherapy. 2017 Sep;37(9):988-989. doi: 10.1002/phar.1975. Epub 2017 Aug 7.
4
CRISPR-Cas13a system: a novel approach to precision oncology.
Cancer Biol Med. 2020 Feb 15;17(1):6-8. doi: 10.20892/j.issn.2095-3941.2019.0325.
5
Giving Up on Precision Oncology? Not So Fast!
Clin Transl Sci. 2017 May;10(3):128-129. doi: 10.1111/cts.12457. Epub 2017 Feb 21.
6
Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Cell. 2018 Apr 19;173(3):535-539. doi: 10.1016/j.cell.2018.04.008.
7
Evolving Paradigms of Personalized Medicine in Oncology.
Natl Med J India. 2017 Nov-Dec;30(6):305-308. doi: 10.4103/0970-258X.239068.
8
Delivering on the promise of precision cancer medicine.
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
9
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol. 2017 Apr 20;35(12):1341-1367. doi: 10.1200/JCO.2016.71.5292. Epub 2017 Feb 1.
10
Genomic Medicine Takes the Stage, Again!
J Natl Compr Canc Netw. 2018 Jul;16(7):795. doi: 10.6004/jnccn.2018.0063.
本文引用的文献
1
Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers.
Int J Mol Sci. 2024 Apr 23;25(9):4600. doi: 10.3390/ijms25094600.
2
Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study.
Int J Mol Sci. 2024 Apr 19;25(8):4478. doi: 10.3390/ijms25084478.
3
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology.
Int J Mol Sci. 2024 Mar 1;25(5):2865. doi: 10.3390/ijms25052865.
4
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.
Int J Mol Sci. 2023 Dec 16;24(24):17560. doi: 10.3390/ijms242417560.
5
Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment.
Int J Mol Sci. 2023 Nov 14;24(22):16307. doi: 10.3390/ijms242216307.
6
Uncovering NOTCH1 as a Promising Target in the Treatment of -Rearranged Leukemia.
Int J Mol Sci. 2023 Sep 23;24(19):14466. doi: 10.3390/ijms241914466.
7
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
Int J Mol Sci. 2023 Sep 7;24(18):13780. doi: 10.3390/ijms241813780.
8
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Int J Mol Sci. 2023 Sep 3;24(17):13618. doi: 10.3390/ijms241713618.
9
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Int J Mol Sci. 2023 Sep 2;24(17):13596. doi: 10.3390/ijms241713596.
10
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets.
Int J Mol Sci. 2023 Aug 9;24(16):12596. doi: 10.3390/ijms241612596.
Zotero 插件